Optimization of rhBMP-2 active-form production in a heterologous expression system using microbiological and molecular genetic approaches


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Recombinant bone morphogenetic protein-2 (rhBMP-2) has pronounced osteoinductive properties, as evidenced by the results of experimental and clinical practices. This applies to both the protein produced in eukaryotic cells and the protein synthesized in bacterial cells. In eukaryotic expression systems, production of the protein is extremely low and, consequently, the cost of materials on its basis is very high. Therefore, optimization of heterologous expression systems for rhBMP-2 production represents an important task. In the present work, optimization of codon composition of the rhBMP-2 gene nucleotide sequence and secondary structure of the transcript, as well as strain selection for efficient gene expression, were carried out. The producing strain based on Escherichia coli BL-21(DE3) provides a high level of rhBMP-2 synthesis (about 57% of total cell proteins). Biological activity of rhBMP-2 dimeric forms purified from the obtained producing strain was measured by induction of alkaline phosphatase activity in C2C12 cells. It is comparable with that of commercial rhBMP-2 expressed in E. coli (R&D Systems, United States). Purified rhBMP-2 does not contain impurities of E. coli endotoxin and can be used in experimental studies of osteoinduction in laboratory animals.

Авторлар туралы

A. Karyagina

Gamaleya Federal Research Center for Epidemiology and Microbiology; Belozersky Research Institute of Physico-Chemical Biology; All-Russia Research Institute of Agricultural Biotechnology

Хат алмасуға жауапты Автор.
Email: akaryagina@gmail.com
Ресей, Moscow, 123098; Moscow, 119991; Moscow, 127550

I. Boksha

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Ресей, Moscow, 123098

T. Grunina

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Ресей, Moscow, 123098

A. Demidenko

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Ресей, Moscow, 123098

M. Poponova

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Ресей, Moscow, 123098

O. Sergienko

Gamaleya Federal Research Center for Epidemiology and Microbiology; All-Russia Research Institute of Agricultural Biotechnology

Email: akaryagina@gmail.com
Ресей, Moscow, 123098; Moscow, 127550

A. Lyaschuk

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Ресей, Moscow, 123098

Z. Galushkina

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Ресей, Moscow, 123098

L. Soboleva

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Ресей, Moscow, 123098

E. Osidak

Gamaleya Federal Research Center for Epidemiology and Microbiology; Imtek Ltd.

Email: akaryagina@gmail.com
Ресей, Moscow, 123098; Moscow, 121552

A. Semikhin

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Ресей, Moscow, 123098

A. Gromov

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Ресей, Moscow, 123098

V. Lunin

Gamaleya Federal Research Center for Epidemiology and Microbiology; All-Russia Research Institute of Agricultural Biotechnology

Email: akaryagina@gmail.com
Ресей, Moscow, 123098; Moscow, 127550

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Allerton Press, Inc., 2016